A randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on hemodialysis

Overview of attention for article published in International Journal of Nephrology and Renovascular Disease, April 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

googleplus: 1 Google+ user

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 19 Mendeley

Summary Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Dove Medical Press (NZ) Ltd, 22 Apr 2014

Background: Genz-644470 is a new, nonabsorbed phosphate binding polymer. In an in vitro competitive ... Background: Genz-644470…